Tainted ED
This article was originally published in The Tan Sheet
Executive Summary
New York-based EG Labs voluntarily recalls all lots of its Viapro 375mg capsules after FDA found an undisclosed ingredient - thiomethisosildenafil, an analog of an active ingredient in prescription erectile dysfunction drugs. The capsules were sold by retailers nationwide and were packaged in one- and two-count blister packs and 10-count bottles. The product has not been sold since March 2008, the firm says. In another recent case, FDA seized $74,000 in mislabeled erectile dysfunction supplements from SEI Pharmaceuticals (1"The Tan Sheet" July 28, 2008, p. 15)...
You may also be interested in...
FDA Maintains Pressure Against Adulterated ED Supplements
FDA says its seizure of $74,000 in mislabeled erectile dysfunction supplements from SEI Pharmaceuticals July 24 demonstrates the steps the agency will take when a company fails to heed a warning about an allegedly adulterated product
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.